To test whether eIF5B promotes GBM cell viability, we used RNA interference to deplete eIF5B in five established GBM cell lines (U343, U251N, A172, U373, and U87MG) with diverse genetic backgrounds (p53, PTEN, EGFR, and MGMT status) (Table S1). This evidence concerns the gene PTEN and glioblastoma.